Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
PaperCitations, authors & open-access status
Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 576 citations, 2014 year and closed oa status.
576
Citations
2014
Year
closed
OA Status